Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 9:12:951383.
doi: 10.3389/fcimb.2022.951383. eCollection 2022.

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador

Rommel Guevara  1 , Belén Prado-Vivar  1 , Sully Márquez  1 , Erika B Muñoz  1 , Mateo Carvajal  1 , Juan José Guadalupe  2 , Mónica Becerra-Wong  1 , Stefanie Proaño  1 , Rosa Bayas-Rea  1 , Josefina Coloma  3 , Michelle Grunauer  4 , Gabriel Trueba  1 , Patricio Rojas-Silva  1 , Verónica Barragán  1 , Paúl Cárdenas  1
Affiliations

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador

Rommel Guevara et al. Front Cell Infect Microbiol. .

Abstract

SARS-CoV-2 reinfection is defined as a new infection with a different virus variant in an individual who has already recovered from a previous episode of COVID-19. The first case of reinfection in the world was described in August 2020, since then, reinfections have increased over time and their incidence has fluctuated with specific SARS-CoV-2 variant waves. Initially, reinfections were estimated to represent less than 1% of total COVID-19 infections. With the advent of the Omicron variant, reinfections became more frequent, representing up to 10% of cases (based on data from developed countries). The frequency of reinfections in Latin America has been scarcely reported. The current study shows that in Ecuador, the frequency of reinfections has increased 10-fold following the introduction of Omicron, after 22 months of surveillance in a single center of COVID-19 diagnostics. Suspected reinfections were identified retrospectively from a database of RT-qPCR-positive patients. Cases were confirmed by sequencing viral genomes from the first and second infections using the ONT MinION platform. Monthly surveillance showed that the main incidence peaks of reinfections were reached within four to five months, coinciding with the increase of COVID-19 cases in the country, suggesting that the emergence of reinfections is related to higher exposure to the virus during outbreaks. This study performed the longest monitoring of SARS-CoV-2 reinfections, showing an occurrence at regular intervals of 4-5 months and confirming a greater propensity of Omicron to cause reinfections.

Keywords: COVID-19; SARS-CoV-2; genomic epidemiology; reinfection; sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart for the selection of suspected reinfections. The database includes tests performed at IM-USFQ from May 2020 to February 2022. Suspected cases were identified retrospectively, first by patients who reported more than one positive test, and then by the compliance with inclusion criteria: at least 45 days between infections, or less if the Ct revealed a higher viral load in the reinfection. From the 44 patients who accomplished inclusion criteria, 22 were considered for sequencing.
Figure 2
Figure 2
Monthly surveillance of reinfections. Suspected cases identified each month within the 22 months period (A) and the corresponding incidence regarding the total SARS-CoV-2 positive tests (B).
Figure 3
Figure 3
Timing of reinfections and variants identified. Plot of the first and second infection detected for each patient (y-axis) over the 22-month surveillance period (x-axis). Each identified variant is represented in different colors.
Figure 4
Figure 4
Phylogram of paired sequences. Only paired consensus sequences were used and rooted to the Wuhan-Hu’s SARS-CoV-2 reference genome. Each pair is represented in different colors. Bootstraps equal to or above 70 are shown.
See this image and copyright information in PMC

References

    1. Abu-Raddad L. J., Chemaitelly H., Coyle P., Malek J. A., Ahmed A. A., Mohamoud Y. A., et al. (2021). SARS-CoV-2 SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine 35:100861. doi: 10.1016/j.eclinm.2021.100861 - DOI - PMC - PubMed
    1. Akkız H. (2022). The biological functions and clinical significance of SARS-CoV-2 variants of corcern. Front. Med. 9. doi: 10.3389/fmed.2022.849217 - DOI - PMC - PubMed
    1. Al-Aly Z., Bowe B., Xie Y. (2022). Outcomes of SARS-CoV-2 Reinfection. Research Square. doi: 10.21203/rs.3.rs-1749502/v1 - DOI
    1. Bakker B. (2021) COVID-19 in Latin America a high toll on lives and livelihoods. Available at: http://elibrary.imf.org/view/journals/001/2021/168/001.2021.issue-168-en... (Accessed June 22, 2022).
    1. Barber R. M., Sorensen R. J. D., Pigott D. M., Bisignano C., Carter A., Amlag J. O., et al. (2022). Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet 399, 2351–2380. doi: 10.1016/S0140-6736(22)00484-6 - DOI - PMC - PubMed

Supplementary concepts